The store will not work correctly when cookies are disabled.
2-(1H-imidazol-5-yl)-N-(1-methylcyclopropyl)pyrido[3,4-d]pyrimidin-4-amine
ID: ALA4483614
PubChem CID: 135390677
Max Phase: Preclinical
Molecular Formula: C14H14N6
Molecular Weight: 266.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(Nc2nc(-c3cnc[nH]3)nc3cnccc23)CC1
Standard InChI: InChI=1S/C14H14N6/c1-14(3-4-14)20-12-9-2-5-15-6-10(9)18-13(19-12)11-7-16-8-17-11/h2,5-8H,3-4H2,1H3,(H,16,17)(H,18,19,20)
Standard InChI Key: KYOJYBUWMHUNGS-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
4.0983 -10.9124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5111 -10.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6935 -10.2021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6511 -13.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7438 -13.8804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5438 -14.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0981 -11.8492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0970 -12.6729 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8092 -13.0819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8074 -11.4362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5201 -11.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5209 -12.6688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2335 -13.0758 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9418 -12.6650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9371 -11.8388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2280 -11.4313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2236 -10.6100 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3931 -12.7335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9470 -13.3397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5021 -9.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 1 0
5 6 1 0
6 19 2 0
18 4 2 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
16 17 1 0
14 4 1 0
18 19 1 0
17 2 1 0
2 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 266.31 | Molecular Weight (Monoisotopic): 266.1280 | AlogP: 2.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.38 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.88 | CX Basic pKa: 5.43 | CX LogP: 1.02 | CX LogD: 1.01 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -0.47 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |